September 26, 2016 9:42 AM ET

Capital Markets

Company Overview of PT Bursa Komoditi dan Derivatif Indonesia

Company Overview

PT Bursa Komoditi dan Derivatif Indonesia operates a regulated exchange for trading global and regional commodity products within the Asian time zone. It specializes in various commodity derivatives, which include metals, soft agricultural products, and energy. The company also focuses on indigenous commodities, including crude palm oil, coal, natural gas, cocoa, coffee, and tin. PT Bursa Komoditi dan Derivatif Indonesia, through its subsidiary, undertakes various clearing, settlement, and risk management functions. It serves individual traders, hedgers, and institutions. The company was founded in 2010 and is based in Jakarta, Indonesia.

Jl. Letjen. S Parman Kav. 73

Suite A

Jakarta,  11410

Indonesia

Founded in 2010

Phone:

62 21 536 2393

Fax:

62 21 548 2652

Key Executives for PT Bursa Komoditi dan Derivatif Indonesia

Chief Executive Officer
Chief Operating Officer
Compensation as of Fiscal Year 2016.

PT Bursa Komoditi dan Derivatif Indonesia Key Developments

PT Bursa Komoditi dan Derivatif Indonesia Presents at 11th Annual FIA Asia Derivatives Conference, Dec-08-2015

PT Bursa Komoditi dan Derivatif Indonesia Presents at 11th Annual FIA Asia Derivatives Conference, Dec-08-2015 . Venue: The St. Regis Singapore00000, afasfsaf, Singapore, Singapore. Speakers: Megain Widjadja, Chief Executive Officer.

Widjaja Family May Sell Stake In ICDX

PT Bursa Komoditi dan Derivatif Indonesia (ICDX) stake may be sold. Chief Executive Officer, Megain Widjaja said that the Widjaja family is planning to reduce its controlling stake in ICDX over the next three years. Financial institutions have expressed interest in acquiring stake in ICDX, the official added. The family currently owns between 50% and 60% of the ICDX, he said, without giving details regarding the size or a valuation for the planned stake sale. Eka Tjipta Widjaja, Megain Widjaja grandfather said, “We want to increase transparency and accountability. We want to open up the market to shareholders that will bring strategic values to expand ICDX to the global stage.” According to the official, firms based outside of Indonesia would be able to own as much as 40% of ICDX, said Widjaja. The company is also open to local partners, and may consider an initial public offering after the planned stake reduction.

Indonesia Commodity and Derivatives Exchange Presents at 10th Annual Asia Derivates Conference 2014, Dec-03-2014

Indonesia Commodity and Derivatives Exchange Presents at 10th Annual Asia Derivates Conference 2014, Dec-03-2014 . Venue: The St. Regis, Singapore. Speakers: Megain Widjaja, Chief Executive Officer.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PT Bursa Komoditi dan Derivatif Indonesia, please visit www.icdx.co.id. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.